Source: http://health.yahoo.net/news/s/nm/celltrion-s-biosimilar-remicade-gets-eu-green-light
Saturday 29 June 2013
Celltrion's biosimilar Remicade gets EU green light
LONDON (Reuters) - European regulators have recommended approval of a copycat version of the blockbuster rheumatoid arthritis drug Remicade, the first time a green light has been given for such an antibody-based medicine. The European Medicines Ag...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.